CAP24 is the first and only FDA-approved surgical paddle lead purpose-built for physiologic, dose-controlled closed-loop ...
Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the ...
Mark G. Lebwohl, M.D. will be installed as the inaugural professor at a ceremony held today at Hatch Auditorium at The Mount ...
Radiopharmaceutical development leader brings over two decades of global oncology clinical experience to Lila Bio, including ...
(NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation ...
Dr. Tuakli currently serves as an Independent Non-Executive Director of Zenith Bank Ghana, where she has chaired the Finance ...
The Cala kIQ Plus System, cleared by FDA earlier this year, is the first and only wearable neuromodulation device for hand ...
Cognizant will apply its life sciences and technology experience to support Gilead's development and operations environment.
Through this expanded partnership, Mint Pharmaceuticals and Bayer Inc. aim to maintain high standards of distribution and ...
A global research team will analyze complex biological patterns to anticipate treatment response and flares — advancing ...
JOHNSTON, Iowa, Oct. 6, 2026 /PRNewswire/ -- Vylor, Inc. (NYSE: VYLR) today announced it will release its third quarter 2026 ...
GigHz highlights a peer-reviewed analysis of 1,430 authorization records and the broader question of what it will take to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results